P
Patrick Oeckl
Researcher at University of Ulm
Publications - 88
Citations - 3346
Patrick Oeckl is an academic researcher from University of Ulm. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 26, co-authored 63 publications receiving 2073 citations. Previous affiliations of Patrick Oeckl include German Center for Neurodegenerative Diseases & Radboud University Nijmegen.
Papers
More filters
Journal ArticleDOI
Cerebrospinal fluid and blood biomarkers for neurodegenerative dementias: An update of the Consensus of the Task Force on Biological Markers in Psychiatry of the World Federation of Societies of Biological Psychiatry
Piotr Lewczuk,Peter Riederer,Sid E. O'Bryant,Marcel M. Verbeek,Bruno Dubois,Pieter Jelle Visser,Kurt A. Jellinger,Sebastiaan Engelborghs,Alfredo Ramirez,Lucilla Parnetti,Clifford R. Jack,Charlotte E. Teunissen,Harald Hampel,Alberto Lleó,Frank Jessen,Lidia Glodzik,Mony J. de Leon,Anne M. Fagan,José Luis Molinuevo,Willemijn J. Jansen,Bengt Winblad,Leslie M. Shaw,Ulf Andreasson,Markus Otto,Brit Mollenhauer,Jens Wiltfang,Martin R Turner,Inga Zerr,Ron Handels,Alexander G. Thompson,Gunilla Johansson,Natalia Ermann,John Q. Trojanowski,Ilker Karaca,Holger Wagner,Patrick Oeckl,Linda J C van Waalwijk van Doorn,Maria Bjerke,Dimitrios Kapogiannis,H. Bea Kuiperij,Lucia Farotti,Yi Li,Brian A. Gordon,Stéphane Epelbaum,Stephanie J.B. Vos,Catharina J.M. Klijn,William E. Van Nostrand,Carolina Minguillon,Matthias Schmitz,Carla Gallo,Andrea Lopez Mato,Florence Thibaut,Simone Lista,Daniel Alcolea,Henrik Zetterberg,Kaj Blennow,Johannes Kornhuber +56 more
TL;DR: In the 12 years since the publication of the first Consensus Paper of the WFSBP on biomarkers of neurodegenerative dementias, enormous advancement has taken place in the field, and the Task Force takes the opportunity to extend and update the original paper.
Journal ArticleDOI
Neurofilaments in the diagnosis of motoneuron diseases: a prospective study on 455 patients
Petra Steinacker,Emily Feneberg,Jochen H. Weishaupt,Johannes Brettschneider,Hayrettin Tumani,Peter M. Andersen,Christine A. F. von Arnim,Sarah Böhm,Jan Kassubek,Christian Kubisch,Christian Kubisch,Dorothée Lulé,Hans-Peter Müller,Rainer Muche,Elmar H. Pinkhardt,Patrick Oeckl,Angela Rosenbohm,Sarah Anderl-Straub,Alexander E Volk,Alexander E Volk,Patrick Weydt,Albert C. Ludolph,Markus Otto +22 more
TL;DR: Neurofilaments in CSF have a high relevance for the differential diagnosis of MNDs and should be included in the diagnostic work-up of patients and their value as prognostic markers should be investigated further.
Journal ArticleDOI
Neurofilament levels as biomarkers in asymptomatic and symptomatic familial amyotrophic lateral sclerosis
Patrick Weydt,Patrick Oeckl,André Huss,Kathrin Muller,Alexander E Volk,Alexander E Volk,Jens Kuhle,Antje Knehr,Peter M. Andersen,Peter M. Andersen,Johannes Prudlo,Petra Steinacker,Jochen H. Weishaupt,Albert C. Ludolph,Markus Otto +14 more
TL;DR: In this article, the authors found that neurofilaments are elevated in cerebrospinal fluid (CSF) and serum of amyotrophic lateral sclerosis (ALS) patients.
Journal ArticleDOI
Glial Fibrillary Acidic Protein in Serum is Increased in Alzheimer's Disease and Correlates with Cognitive Impairment.
Patrick Oeckl,Steffen Halbgebauer,Sarah Anderl-Straub,Petra Steinacker,André Huss,Hermann Neugebauer,Christine A. F. von Arnim,Janine Diehl-Schmid,Timo Grimmer,Johannes Kornhuber,Piotr Lewczuk,Piotr Lewczuk,Adrian Danek,Albert C. Ludolph,Markus Otto +14 more
TL;DR: Serum GFAP correlated with the Mini-Mental State Examination score and might be a follow-up marker in clinical trials and the first blood biomarker in the differential diagnosis of AD and bvFTD.
Journal ArticleDOI
Neurofilament light chain in serum for the diagnosis of amyotrophic lateral sclerosis
Federico Verde,Petra Steinacker,Jochen H. Weishaupt,Jan Kassubek,Patrick Oeckl,Steffen Halbgebauer,Hayrettin Tumani,Christine A. F. von Arnim,Johannes Dorst,Emily Feneberg,Benjamin Mayer,Hans-Peter Müller,Martin Gorges,Angela Rosenbohm,Alexander E Volk,Vincenzo Silani,Albert C. Ludolph,Markus Otto +17 more
TL;DR: Serum NFL is increased in ALS in comparison to other conditions and can serve as diagnostic and prognostic biomarker and establish a cut-off level for the diagnosis of ALS.